Search

Home > Cell & Gene: The Podcast > The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier
Podcast: Cell & Gene: The Podcast
Episode:

The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier

Category: Science & Medicine
Duration: 00:21:42
Publish Date: 2023-02-16 09:00:00
Description:

On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Andy Ramelmeir, EVP Head of Technical Operations at Sangamo Therapeutics, a biotech based in Brisbane, California that applies cell and gene therapy to combat Hemophilia A and other genetic diseases. Ramelmeir explains the why behind the company's decision to build its own Phase 1/2 cGMP AAV in-house facility. He also talks broadly about manufacturing cell and gene therapies and the potential and realistic solutions to needed to drive down manufacturing costs.

Total Play: 0